Tarsus Pharmaceuticals Future Growth
Future criteria checks 5/6
Tarsus Pharmaceuticals is forecast to grow earnings and revenue by 64.8% and 39.1% per annum respectively while EPS is expected to grow by 65% per annum.
Key information
64.8%
Earnings growth rate
65.0%
EPS growth rate
| Pharmaceuticals earnings growth | 23.7% |
| Revenue growth rate | 39.1% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 27 Sep 2024 |
Recent future growth updates
Analysts Are Upgrading Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Latest Results
May 11
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Mar 01Recent updates
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable
Sep 05Tarsus Pharmaceuticals: Strong Execution In Eye Disease Treatment
Aug 20With A 26% Price Drop For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) You'll Still Get What You Pay For
Jun 26Following Up On Tarsus Pharmaceuticals
May 28Analysts Are Upgrading Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Latest Results
May 11Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name
Mar 08Rainbows and Unicorns: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Analysts Just Became A Lot More Optimistic
Mar 03Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Mar 01Is Tarsus Pharmaceuticals (NASDAQ:TARS) A Risky Investment?
Feb 28New Forecasts: Here's What Analysts Think The Future Holds For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Nov 12What Does The Future Hold For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)? These Analysts Have Been Cutting Their Estimates
Aug 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 474 | 96 | N/A | N/A | 4 |
| 12/31/2025 | 276 | -76 | N/A | N/A | 6 |
| 12/31/2024 | 164 | -137 | N/A | N/A | 5 |
| 6/30/2024 | 83 | -150 | -129 | -124 | N/A |
| 3/31/2024 | 43 | -148 | -139 | -133 | N/A |
| 12/31/2023 | 17 | -136 | -123 | -117 | N/A |
| 9/30/2023 | 14 | -108 | -95 | -89 | N/A |
| 6/30/2023 | 13 | -91 | -77 | -75 | N/A |
| 3/31/2023 | 28 | -65 | -56 | -56 | N/A |
| 12/31/2022 | 26 | -62 | -50 | -49 | N/A |
| 9/30/2022 | 16 | -63 | -51 | -50 | N/A |
| 6/30/2022 | 17 | -56 | -25 | -25 | N/A |
| 3/31/2022 | 24 | -44 | 0 | 0 | N/A |
| 12/31/2021 | 57 | -14 | 3 | 4 | N/A |
| 9/30/2021 | 57 | -10 | 6 | 6 | N/A |
| 6/30/2021 | 55 | -5 | -8 | -8 | N/A |
| 3/31/2021 | 33 | -15 | -32 | -31 | N/A |
| 12/31/2020 | N/A | -27 | -22 | -21 | N/A |
| 9/30/2020 | N/A | -17 | -12 | -12 | N/A |
| 6/30/2020 | N/A | -7 | -6 | -6 | N/A |
| 3/31/2020 | N/A | -5 | -5 | -5 | N/A |
| 12/31/2019 | N/A | -5 | -4 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TARS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: TARS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TARS is expected to become profitable in the next 3 years.
Revenue vs Market: TARS's revenue (39.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: TARS's revenue (39.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TARS's Return on Equity is forecast to be high in 3 years time